Sexual and reproductive health
Kisspeptin-54
Also called Metastin
per administration
A human trial worked out how much to take and how often, so a dosing schedule is shown.
The human evidence for Kisspeptin-54 used the intravenous route. The draw worked out here assumes a subcutaneous injection, so the amount is not a direct read-across.
Quick start
Kisspeptin-54 at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 100–400 mcg per administration
- How often
- 3x per week
- Where
- Intravenous (clinical setting)
- Time to steady level
- ~3 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for Kisspeptin-54 describe 100–400 mcg per administration. Descriptive only, not a recommendation.
About 20–30 minutes; the decay chart is largely illustrative here.
Human studies delivered kisspeptin-54 by intravenous infusion to probe gonadotropin release; no subcutaneous schedule is established, so no schedule table is shown.
Modelled level — 3x per week
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 3hours
- Administrations
- 3/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Kisspeptin-54 reproductive-axis studies (Dhillo group)Intravenous kisspeptin-54 infusions were used to stimulate gonadotropin secretion in volunteers.